Patterns of Use of Perioperative Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Bypass Graft Surgery With Cardiopulmonary Bypass: Effects on In-Hospital Morbidity and Mortality

Study Questions:

Does use of angiotensin-converting enzyme inhibitor (ACEI) in the perioperative period in patients undergoing coronary artery bypass surgery (CABG) with cardiopulmonary bypass (CPB) have an effect on in-house morbidity and mortality?